首页> 美国卫生研究院文献>other >Revisiting the Value of Competition Assays in Folate Receptor-Mediated Drug Delivery
【2h】

Revisiting the Value of Competition Assays in Folate Receptor-Mediated Drug Delivery

机译:在叶酸受体介导的药物传递中重新探讨竞争分析的价值

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Polymeric nanoparticles have been studied for gene and drug delivery. These nanoparticles can be modified to utilize a targeted delivery approach to selectively deliver their payload to specific cells, while avoiding unwanted delivery to healthy cells. One commonly over-expressed receptor which can be targeted by ligand-conjugated nanoparticles is the folate receptor alpha (FRα). The ability to target FRα remains a promising concept, and therefore, understanding the binding dynamics of the receptor with the ligand of the nanoparticle therapeutic can provide valuable insight. This manuscript focuses on the interaction between self-assembled nanoparticles decorated with a folic acid (FA) ligand and FRα. The nanoparticles consist of micelles formed with a FA conjugated triblock copolymer (PEI-g-PCL-b-PEG-FA) which condensed siRNA to form micelleplexes. By combining biological and biophysical approaches, this manuscript explores the binding kinetics and force of the targeted siRNA containing nanoparticles to FRα in comparison with free FA. We demonstrate via flow cytometry and atomic force microscopy that multivalent micelleplexes bind to FRα with a higher binding probability and binding force than monovalent FA. Furthermore, we revisited why competitive inhibition studies of binding of multivalent nanoparticles to their respective receptor are often reported in literature to be inconclusive evidence of effective receptor targeting. In conclusion, the results presented in this paper suggest that multivalent targeted nanoparticles display strong receptor binding that a monovalent ligand may not be able to compete with under in vitro conditions and that high concentrations of competing monovalent ligands can lead to measurement artifacts.
机译:已经研究了聚合物纳米颗粒用于基因和药物的递送。可以修饰这些纳米颗粒以利用靶向递送方法来选择性地将其有效载荷递送至特定细胞,同时避免不希望的递送至健康细胞。叶酸受体α(FRα)是一种通常被配体缀合的纳米粒子靶向的受体。靶向FRα的能力仍然是一个有前途的概念,因此,了解受体与纳米粒子治疗剂配体的结合动力学可以提供有价值的见解。该手稿着重于装饰有叶酸(FA)配体的自组装纳米颗粒与FRα之间的相互作用。纳米粒子由与FA共轭三嵌段共聚物(PEI-g-PCL-b-PEG-FA)形成的胶束组成,该三聚体共聚物将siRNA缩合形成胶束复合物。通过结合生物学和生物物理方法,该手稿探索了与游离FA相比,含有靶向siRNA的纳米颗粒与FRα的结合动力学和作用力。我们通过流式细胞仪和原子力显微镜证明,多价胶束与FRα的结合概率和结合力比单价FA高。此外,我们重新审视了为什么在文献中经常报道多价纳米粒子与其各自受体结合的竞争性抑制研究不是有效受体靶向的结论性证据。总之,本文提出的结果表明,多价靶向纳米粒子显示出强大的受体结合力,一价配体可能无法在体外条件下竞争,高浓度的竞争性单价配体会导致测量伪影。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号